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Study Design: Retrospective review.
Purpose: To identify the trends in stimulator use, pair those trends with various grafting materials, and determine the influence of
stimulators on the risk of revision surgery.
Overview of Literature: A large number of studies has reported beneficial effects of electromagnetic energy in healing long bone
fractures. However, there are few clinical studies regarding the use of electrical stimulators in spinal fusion.
Methods: We used insurance billing codes to identify patients with lumbar disc degeneration who underwent anterior lumbar interbody fusion (ALIF). Comparisons between patients who did and did not receive electrical stimulators following surgery were performed using logistic regression analysis, chi-square test, and odds ratio (OR) analysis.
Results: Approximately 19% of the patients (495/2,613) received external stimulators following ALIF surgery. There was a slight increase in stimulator use from 2008 to 2014 (multi-level R 2=0.08, single-level R 2=0.05). Patients who underwent multi-level procedures
were more likely to receive stimulators than patients who underwent single-level procedures (p <0.05; OR, 3.72; 95% confidence
interval, 3.02–4.57). Grafting options associated with most frequent stimulator use were bone marrow aspirates (BMA) plus autograft
or allograft for single-level and allograft alone for multi-level procedures. In both cohorts, patients treated with bone morphogenetic
proteins were least likely to receive electrical stimulators (p <0.05). Patients who received stimulation generally had higher reimbursements. Concurrent posterior lumbar fusion (PLF) (ALIF+PLF) increased the likelihood of receiving stimulators (p <0.05). Patients who
received electrical stimulators had similar revision rates as those who did not receive stimulation (p >0.05), except those in the multilevel ALIF+PLF cohort, wherein the patients who underwent stimulation had higher rates of revision surgery.
Conclusions: Concurrent PLF or multi-level procedures increased patients’ likelihood of receiving stimulators, however, the presence
of comorbidities did not. Patients who received BMA plus autograft or allograft were more likely to receive stimulation. Patients with
and without bone stimulators had similar rates of revision surgery.
Keywords: Lumbar spine; Intervertebral disc degeneration; Stimulators; Grafts; Costs and cost analysis
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Introduction
Considerable evidence supports the use of electromagnetic energy to help heal long bone fractures. However, few
clinical studies have examined electrical stimulators with
spinal fusion, especially with anterior lumbar interbody
fusion (ALIF). With the aging population, the prevalence
of spinal degenerative conditions and fusion surgeries to
address such pathologies has increased [1,2]. Fusion success is associated with patient outcomes; therefore, the
methods to improve fusion rates may provide clinical and
financial advantages [3-6].
In 1974, Dwyer and Wickham [7] published results
demonstrating the benefit of direct current stimulation
(DCS) for lumbar spinal fusion. Thereafter, Kane [8] conducted a randomized prospective trial wherein DCS resulted in higher fusion success rates than non-stimulated
patients, even among high-risk patients. Patients are considered to be at high-risk if they were smokers, morbidly
obese, diabetic, had spondylolisthesis, or were undergoing
a reoperation or multi-level fusion [7-9].
Non-invasive, external alternatives to DCS include
pulsed electromagnetic field stimulation (PEMFS) and
capacitive coupled electrical stimulation [10]. These
techniques are advantageous over DCS in terms of lower
operating times, blood loss, hardware removal, and infection potential. In 1990, Mooney [11] demonstrated more
favorable fusion outcomes among compliant patients with
external stimulators; however, they did not stratify their
results based on the anterior and posterior approaches.
Moreover, other animal studies have not corroborated
these results [9,12]. This suggests that the benefits of electrical stimulation depend on factors, such as regions of
the spine or surgical approach or that improvements in
surgical technique since the Mooney study have mitigated
the potential benefit of the stimulators.
Recent basic science studies have proposed that external
electromagnetic bone stimulators work via the upregulation of bone growth factors, including bone morphogenetic proteins (BMPs) [13]. Some grafting materials are
employed for similar purposes. ALIFs can be supplemented with autograft, allograft, recombinant-human
BMP, bone marrow aspirate (BMA), or a combination of
these. Iliac crest bone graft (ICBG) remains the ‘gold standard’ of grafting materials because of its minimal immune
response and optimal osteogenic, osteoconductive, and
osteoinductive properties. However, it is found to have
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high donor site morbidity, greater neurovascular injury,
and increased operation time. Allograft, BMP, and BMAs
are alternatives that are less invasive alternatives; however,
they lack some of bone growth qualities that make ICBG
ideal [14,15].
This study aimed to identify the trends in bone stimulator usage, determine the prevalence of different grafting
materials used for ALIF procedures with and without
stimulators, as well as compare the incidence of revision
surgery between patients who did and did not receive
bone stimulation. We also aimed to assess the costs associated with these procedures.

Materials and Methods
We used the PearlDiver Patient Record Database (PearlDiver Technologies Inc., Warsaw, IN, USA; http://www.
pearldiverinc.com/) to follow up patients longitudinally
for 1 year after their initial ALIF or ALIF+posterior lumbar fusion (PLF) surgery (ALIF+PLF=ALIF with concomitant PLF). Patient groups were divided as per the Current
Procedural Terminology and the International Classification of Diseases, 9th edition insurance billing codes. We
focused on patients within the database who were insured
through Humana (Louisville, KY, USA) because the Humana population involved a wide age range and included
nearly 20 million patients from the beginning of 2007 to
the third quarter of 2015.
All the patients included in this study had lumbar disc
degeneration within a year prior to their index procedure.
Further, no patient had fractures or cancers of the spine.
Surgery type was classified as single- versus multi-level
and ALIF-only versus ALIF+PLF. Throughout this paper,
unless otherwise specified, ‘ALIF’ includes all patients
who underwent only ALIF or ALIF+PLF procedure. To
stratify patients based on the grafting material, we identified patients billed for autograft, allograft, autograft and
allograft, BMA, BMP, BMA+graft, and BMP+graft on
the day of their index procedure.
We determined how many patients from each group
were billed for electrical stimulators within 3 months of
their index ALIF procedure. Thereafter, we compared the
number of patients who underwent a second surgery between those who did and did not receive stimulation. Any
ALIF, PLF, PLIF, discectomy, or laminectomy performed
within a year of the index ALIF was considered a revision
surgery.
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Incidence per 10,000 patients single- vs. multi-level ALIF (general)
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Fig. 1. Age trends among patients undergoing ALIF. Single-ALIFs are performed on a slightly younger population. ALIF, anterior
lumbar interbody fusion.

Statistical analyses were performed using chi-square
analysis or R software (https://www.r-project.org/) for
logistic regression. Significance was set at p<0.05. Odds
ratio (OR) data were included with a 95% confidence
interval (CI) where comparisons could be made in a 2×2
contingency table.
The analyzed cost data indicate the average amount
Humana reimbursed to physicians and facilities for all the
costs incurred by the patient for their care over a one-day
or a 1-year period from the date of surgery. Due to the
data being de-identified and commercially available, no
Institutional Review Board approval was needed.

250
200
150
100
50
0

2011
2012
2013
2014
Year
Single-level ALIF-only
Multi-level ALIF-only
Single-level ALIF+PLF
Multi-level ALIF+PLF
Fig. 2. An increase in the use of single- and multi-level ALIFs from
2008 to 2014, both with and without concurrent PLF procedures. ALIF,
anterior lumbar interbody fusion; PLF, posterior lumbar fusion.

In the Humana subset of the PearlDiver database, between
January 2007 and December 2014, 2,613 patients underwent ALIF within a year of lumbar disc degeneration
diagnosis. Of those patients, 1,520 (58.2%) were billed for
single-level and 1,093 (41.8%) were billed for multi-level
ALIF. The ALIF was combined with a PLF (ALIF+PLF) in
42.4% of the single-level fusion patients and 49.6% of the
multi-level fusion patients. ALIF+PLF patients underwent
multi-level fusions more commonly than the ALIF-only
patients (X2 p<0.05; OR, 1.590; 95% CI, 1.36–1.86).
After adjusting for the number of patients included in
the database in each age group, single-level ALIF procedures were found to be most frequent in patients aged
45–49 years, while multi-level ALIF procedures were most
frequent among patients aged 60–64 years (Fig. 1). Men
were slightly more likely to undergo single-level ALIF,
while women were slightly more likely to undergo multi-

Patients (%)

Results
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80
60
40
20
0
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2010

Small decrease in percentage of patients not
billed for stimulators with ALIF-only
93.1 87.8 83.2 89.6
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85.7

64.9 64.2
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Multi-level ALIF-only
Linear (single-level ALIF-only)
Linear (multi-level ALIF-only)

Fig. 3. Percentage of patients who did not receive stimulators following a single- or multi-level ALIF-only procedure. A minor decrease in
the percentage of patients who did not receive stimulation indicates
a minor increase in patients receiving stimulators following ALIF-only
procedures. ALIF, anterior lumbar interbody fusion.

level ALIF (p<0.05 for ALIF-only and ALIF+PLF).
The number of patients who underwent single- or
multi-level ALIF procedure increased from 2008 to 2014
even after considering the rise in the population within
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Patients (%)

Small decrease in percentage of patients not billed for
stimulators with ALIF+PLF
R 2=0.0382
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Fig. 4. Percentage of patients who did not receive stimulators following a single- or multi-level ALIF+PLF procedures. A minor decrease in
the percentage of patients who did not receive stimulation indicates a
minor increase in those receiving stimulators following ALIF+PLF procedures. ALIF, anterior lumbar interbody fusion; PLF, posterior lumbar
fusion.

the database (Fig. 2). The percentage of patients who
received stimulators increased only slightly from 2008
to 2014 (Figs. 3, 4). Comorbidities, such as smoking, diabetes, and obesity that were diagnosed on the day of the
index procedure did not significantly influence the likelihood of stimulator use (p>0.05 for all).
Total 495 patients (18.9%) were billed for an external
stimulator within 3 months of their ALIF. No patient was
billed for an internal stimulator. More patients with multilevel ALIFs (334/1,093, 30.6%) underwent stimulation
than those with single-level ALIFs (161/1,520, 10.6%) (X2
p<0.05; OR, 3.72; 95% CI, 3.02–4.57). Similar trends were
observed after specifying if the ALIF was performed in
conjunction with a PLF (X2 p<0.05; ALIF+PLF: 95% OR,
1.48; 95% CI, 1.15–1.89; ALIF-only: OR, 4.59; 95% CI,

Table 1. Total number of patients who receive single-level, multi-level, or any ALIF, and the number and percent of those patients who were billed
for an external stimulator within 3 months of that procedure

Variable

Total patients

Stimulated patients (%)

Significant difference
p <0.05

ALIF-only
Single-level ALIF-only
Multi-level ALIF-only
ALIF

933

76 (8.1)

494

143 (28.9)

1,427

219 (15.3)

p <0.05

ALIF+PLF
Single-level ALIF+PLF

644

101 (15.7)

Multi-level ALIF+PLF

542

174 (32.1)

1,186

275 (23.1)

ALIF

p <0.05

General ALIF
Single-level ALIF

1,520

161 (10.6)

Multi-level ALIF

1,093

334 (30.6)

ALIF

2,613

495 (18.9)

ALIF, anterior lumbar interbody fusion; PLF, posterior lumbar fusion.
Multi-level ALIF patients were significantly more likely to be billed for stimulators for ALIF+PLF and ALIF-only patients (and ALIF in general) (p <0.05).
Table 2. Correlation of stimulator use with revision surgery

Stimulated

Revision (%)

Non-stimulated

Revision (%)

p -value

ALIF-only

69

<11

799

54 (6.8)

0.3442

ALIF+PLF

91

<11

522

21 (4.0)

0.2814

Variable
Single-level

Multi-level
ALIF-only

125

11 (8.8)

326

29 (8.9)

0.3013

ALIF+PLF

156

17 (10.9)

342

13 (3.8)

0.0005

In three of four patient groups, stimulators did not appear to significantly affect the likelihood of undergoing revision surgery, and in four of four
groups did not reduce the likelihood of revision surgery. Patients who received stimulators after a primary multi-level ALIF+PLF were more likely to
undergo a revision surgery compared to patients who did not receive stimulators.
ALIF, anterior lumbar interbody fusion; PLF, posterior lumbar fusion.
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Table 3. Number of patients who received each type of grafting option, and the percentage of those patients who also received stimulators

Single-level

Variable

Multi-level

Total

Stimulated patients (%)

Total

Stimulated patients (%)

Autograft

104

13 (12.5)

100

40 (40.0)

Allograft

146

13 (8.9)

93

30 (32.3)

BMA

94

<11 (<10.6)

40

13 (32.5)

BMP

251

<11 (<4.0)

153

39 (25.5)

60

<11 (<16.7)

47

15 (31.9)

Autograft and allograft
BMA+graft

50

20 (40.0)

36

14 (38.9)

BMP+graft

114

<11 (<8.8)

61

23 (37.7)

BMA, bone marrow aspirate; BMP, bone morphogenetic protein.
Percent of patients billed for stimulators, organized by graft type
45

40.0

Patients (%)

40

40.0
32.5

32.3

35

25.5

25
20
10

16.7

12.5
8.9

10.6

8.8
4.0

5
0

37.7

31.9

30

15

38.9

Autograft
Allograft
BMA
BMP
				
Year
Single-level

Autograft and
allograft

BMA+graft

BMP+graft

Multi-level

Fig. 5. Percentage of patients billed for an external stimulator after an ALIF with a specific grafting option. BMA, bone marrow aspirate; BMP, bone morphogenetic protein.

3.39–6.23) (Table 1). Single-level ALIF+PLF patients were
nearly twice as likely to receive stimulators than singlelevel ALIF-only patients (X2 p<0.05; OR, 2.10; 95% CI,
1.53–2.88). Multi-level ALIF+PLF patients were more
likely to receive stimulators than multi-level ALIF-only
patients; however, the result was statistically insignificant
(X2 p=0.27; OR, 1.161; 95% CI, 0.890–1.513).
In three of the four patient groups: single-level ALIFonly, single-level ALIF+PLF, and multi-level ALIF-only,
stimulators had no significant effect on the likelihood of
revision surgery (X2 p>0.05). Patients who received stimulators following a multi-level ALIF+PLF were more likely
to require revision surgery (X2 p<0.05; OR, 3.10; 95% CI,
1.46–6.55) (Table 2).
BMP was the most common grafting option (single-

level 16.5% and multi-level 14.0%), and BMA+graft was
the least common (single-level 3.3% and multi-level 3.3%).
The number of patients who received stimulators in each
of the seven different grafting subgroups is presented in
Table 3. Among the single-level ALIF cohort, patients who
received BMA+graft or allograft+autograft had a higher
likelihood of receiving stimulators (p<0.05). In the multilevel cohort, patients who received allograft, autograft,
BMA+graft, or BMP+graft had a higher likelihood of
receiving stimulators (p<0.05). BMP patients consistently
had a lower likelihood of receiving stimulators (p<0.05)
(Table 3, Fig. 5).
Patients who underwent ALIF+PLF procedures incurred higher costs than those who underwent ALIFonly procedures. Further, in patients with and without
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stimulators, the difference was more pronounced among
those who received stimulators. Patients who eventually
received stimulators incurred a higher cost than those
who did not undergo stimulation, both on the day of the
surgery and over a 1-year period. Generally, over a yearlong period (excluding the day of surgery), patients who
received stimulators within 3 months of ALIF incurred a
39% and 11% higher cost than those who did not receive
stimulators for single- and multi-level procedures, respectively. Notable exceptions were patients grafted with BMA
and allograft or autograft. BMA+graft patients who did
not receive stimulators had, on an average, $15,937 more
health-related costs after a year than similarly grafted patients who received stimulation.

Discussion
1. General trends in stimulator usage
The present data demonstrated variable usage of stimulators. Stimulators were used with a wide range of grafting
materials and were not significantly associated with comorbidities, such as diabetes, smoking, and obesity, at the
time of surgery. However, stimulators were consistently
used more commonly for patients undergoing more complex procedures.
Previous studies recommended the use of electrical
stimulators to aid fusion for ‘high-risk’ patients, including
patients undergoing revision surgery or multi-level fusion
[8,9,11]. Our data were consistent with these recommendations in that stimulators were more commonly used for
patients undergoing multi-level fusion. Moreover, stimulators were used more frequently for patients undergoing
ALIF+PLF rather than ALIF-only. We believe that patients
undergoing ALIF+PLF represented more severe cases
than those undergoing ALIF-only. Patients who received
concurrent PLFs were more likely to receive stimulators
for single- and multi-level procedures; however, the result
was only significant for single-level procedures.
In previous studies, patients who were diabetic, obese,
and smoked were also considered ‘high-risk’ candidates
who could benefit from the use of stimulators [8,9,
11,16,17]. Although two of these studies focused on internal stimulators (DCS), Mooney [11] in 1990 reported that
external stimulation (PEMFS) could lower the adverse
effects of smoking on fusion success. While our data did
not show any significant differences in stimulator usage in
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patients with and without these comorbidities, it would be
worthwhile to evaluate if external stimulators may benefit
these patients in future studies.
2. Trends in grafting materials used in conjunction with
stimulators
Thus far, studies that have analyzed electrical stimulators
have only focused on patients treated with autograft or
allograft. In 1990, Mooney [11] found similar fusion success rates for patients treated with autograft or allograft.
We found that allograft, autograft, or a combination of
these two were among the popular grafting options that
established the use of stimulators; however, patients
treated with BMA+autograft or allograft were consistently
more likely to receive electrical stimulators. Single-level
BMA+graft patients were substantially more likely to
receive stimulators than patients who underwent singlelevel procedures. In contrast, multi-level BMP patients
were substantially less likely to receive stimulators than
patients who underwent multi-level procedures. However,
the most consistent trend among the different grafting
options was that patients who underwent multi-level
procedures were prescribed stimulators more commonly
than those who underwent single-level procedures. Other
grafting options, when compared to the general population of ALIF patients, did not stand out in terms of having
a clear influence on whether or not stimulators were used.
While these data validate the previous discussion regarding patients who undergo multi-level procedures being
more likely to receive stimulation, it also highlights the
diverse population of patients who receive stimulation.
As per previous reports, patients who received BMA
and autograft or allograft were prescribed stimulators
more frequently [13,18-20]. BMA is believed to possess
osteogenicity and osteoinductivity [19]. External electrical
stimulators work on already differentiated cells; therefore, their use may enhance the osteogenic properties of
BMA [13]. Autograft and allograft have osteoconductivity; therefore, BMA, in conjunction with autograft or allograft, may contain all the following three qualities of an
ideal bone graft: osteoconductivity, osteoinductivity, and
osteogenicity [13,20].
3. Costs
From an economic perspective, patients who received

Asian Spine Journal
stimulators were associated with higher costs. On an average, the total cost per patient on the day of surgery was
27% higher for single-level ALIF-only patients who would
eventually receive stimulation than for those who would
not. Most external stimulators are administered after the
day of the surgery; moreover, stimulated patients were
usually associated with higher same-day reimbursements
than non-stimulated patients; therefore, we used this as a
rationale to support the notion that patients who received
stimulators generally represented more complex and/or
challenging cases that required more time and resources.
Patients who received stimulators were also associated
with greater costs over a 1-year period (excluding the day
of the surgery), except for multi-level ALIF patients. The
cost for multi-level ALIF patients treated with BMA+graft
who received stimulators, was on an average $15,937
lower throughout the year than that for those treated with
BMA+graft who did not receive stimulators. However, in
this subgroup, the stimulated patients also had lower costs
on the day of the surgery than those who did not receive
stimulators, potentially indicating less complex cases to
begin with. However, this is an interesting result, considering that stimulators were more commonly for patients
in the BMA+graft subgroup. Future studies should seek to
clarify if stimulators affect the postoperative complication
rates or if their effect is minimal compared to the underlying complexity of the diagnosis.
4. Revision surgery
Although Mooney [11] demonstrated that external stimulators could improve the rates of fusion success in 1990,
to our knowledge, no recent data are available that clearly
demonstrate the benefit of stimulator use. A recent prospective study by Rogozinski et al. [21] in 2009 showed
that DCS did not benefit fusion success in the elderly (age
>60 years) lumbar fusion patients; this was contradictory
to the findings of the 1988 study by Kane et al. [8] that
showed that DCS improved fusion success rates [1]. Although internal stimulators work differently and are used
for different procedures than external stimulators, the
contrasting results of these two studies may indicate that
improvements in modern surgical technique have mitigated the potential benefit of stimulators.
In large-database studies, such as the present one, the
rates of revision surgery are an imperfect proxy for the
estimated clinical outcomes of an index procedure. How-
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ever, considering their invasiveness, financial burden,
and potential for further complications, revision surgeries are important clinical outcomes that physicians and
patients attempt to avoid. We found that in three of the
four patient groups (single-level ALIF-only, single-level
ALIF+PLF, and multi-level ALIF-only), the use of stimulators following the index procedure did not significantly
affect the likelihood of revision surgery. Among multilevel ALIF+PLF patients, those who underwent stimulation exhibited a significantly higher likelihood of revision
surgery. We considered this as more evidence of the fact
that those patients had more complicated underlying
diagnoses. The null effects of stimulators on the revision
rates among the other cohorts were another interesting
result.
Patients may have undergone revision surgery due to
several reasons beyond the scope of what we were able to
determine using insurance billing codes. Our privacy contract with PearlDiver Inc. prevented us from performing a
more stratified analysis of certain patient groups, such as
smokers, because even with a large database, the sample
size was inadequate for such analyses. However, while
there might have been some patient groups for whom
stimulators were beneficial, the data suggested that overall, stimulators overall did not exert a strong influence on
the rates of revision surgery.
This study aimed to report, based on a large-scale perspective research, the trends that have influenced stimulator usage. It is clear that patients who undergo ALIF are
diverse, and the factors that influence the use of stimulators also vary; therefore, we identified that stimulators
were prescribed for more complex and challenging cases
and were more frequently used with BMA plus autograft
or allograft. Our data did not show any positive effect of
stimulator use on the rates of revision surgery; therefore,
future studies should explore specific patient populations
that may benefit from stimulator use.

Conclusions
The present data indicated that physicians tend to prescribe stimulators for more complex and challenging
cases, such as multi-level fusion or ALIF+PLF. Moreover,
we demonstrated that stimulators were more commonly
used in cases where the grafting material was BMA plus
autograft or allograft. However, there was no patient
group wherein the frequency of external stimulator usage
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suggested a clear standard of care.
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